Gauravpal Singh Gill, MD
Interventional Cardiology · Colonial Heights, VANPI 1538689989
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (35.9%), grants and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Abbott at 47.7% of the total.
Across 108 payments — averaging $124.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$6K
- Edwards Lifesciences$4K
- Medtronic$2K
- Abiomed$564
- Shockwave Medical, Inc$256
- Boston Scientific$195
- plus $465 from 13 others
What the payments were for
- Grants$4,50034%
- Travel & lodging$4,82236%
- Food & beverage$3,87129%
- Education$2392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 18 | $6,410 |
| Edwards Lifesciences | 33 | $3,581 |
| Medtronic | 20 | $1,961 |
| Abiomed | 11 | $564 |
| Shockwave Medical, Inc | 2 | $256 |
| Boston Scientific | 3 | $195 |
| Angiodynamics, Inc. | 1 | $99 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $93 |
| Penumbra, Inc. | 2 | $69 |
| Amgen | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Merck | 1 | $20 |
| Novo Nordisk | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Novartis | 1 | $16 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,432 in reported general payments places this provider in the 75th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $14,940 |
| ClopidogrelClopidogrel Bisulfate | 38 | $418 |
| Metoprolol Succinate | 12 | $242 |
| Atorvastatin Calcium | 13 | $107 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $101 |
| Losartan Potassium | 12 | $95 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Colonial Heights
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
- Jason FoerstRoanoke$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.